Asthmapolis partners with Synapse to develop innovative technology for asthma treatment

Asthmapolis, a Wisconsin-based company dedicated to advancements in asthma treatment, has collaborated with Synapse to develop breakthrough technologies for asthma treatment. Combining medication sensors, mobile applications, and analytics, the Asthmapolis sensor attaches to existing rescue inhalers to collect data such as when and where patients experience asthma conditions...

More Information at pharmabiz.com



Asthma fears tackled with hospital help

A YEOVIL mother whose four-year-old daughter has been in and out of hospital more than ten times because of asthma has pledged to give something back to staff who treated her...

Full news here: thisissomerset.co.uk



Team finds new type of severe asthma, can be treated with drugs that suppress the immune system

(Medical Xpress) -- Researchers at the University of Pittsburgh School of Medicine have identified a subset of severe asthma that improves with drug regimens that suppress the immune system. In the American Journal of Respiratory and Critical Care Medicine, they dubbed the condition “asthmatic granulomatosis” after the characteristic small areas of focal inflammation that can be found in the lungs of those who have it...

Read more at: medicalxpress.com